Cleveland Clinic works with OneBlood to start trials for COVID-19 plasma treatment

Cleveland Clinic Florida reports it has received approval to begin clinical trials for a variety of new treatments to help COVID-19-positive patients.

One of the most promising treatments is convalescent plasma therapy, which collects antibody rich plasma from donors who have recovered from COVID-19 to use for patients currently struggling with the virus, the clinic said in a press release. Cleveland Clinic Florida recently received expanded access to use this therapy for those admitted with moderate to severe COVID-19 disease.

Since implementing drive-thru testing in mid-March, Cleveland Clinic Florida sites have been gathering information on patients who are interested in plasma donations and currently has a list of 160 willing participants, the press release says. The convalescent plasma collection will be collected by OneBlood, an independent not-for-profit blood bank serving Florida.  Plasma donations from Cleveland Clinic Florida patients could potentially benefit COVID-19 patients across the entire state. Cleveland Clinic Florida said it continues to refer willing recovered donors who meet criteria to OneBlood daily. OneBlood is known for its distinctive Big Red Bus mobile collection centers.

The OneBlood website says transfusing the plasma that contains the antibodies into a person still fighting the virus can provide a boost to the patient’s immune system and potentially help them recover.

The experimental treatment is approved by the FDA to be used on an emergency basis and is called “COVID-19 convalescent plasma.” Critically ill patients who meet the FDA criteria to receive this therapy can be treated for life-threatening COVID-19.

Dr. Wael Barsoum, CEO and president of Cleveland Clinic Florida

“Our objective throughout the COVID-19 outbreak has been to provide the best possible care for patients, which includes having access to innovative treatments for the virus,” said Dr. Wael Barsoum, CEO and president of Cleveland Clinic Florida. “We are fortunate to have a team of experts who can help advance treatment options that will benefit patients now and in the future.”

The OneBlood website  provides information on how to register as a donor. Donors must meet all the required screening criteria for blood donation and the additional FDA criteria, as follows:

  • Prior diagnosis of COVID-19 documented by an FDA approved laboratory test
    • A positive diagnostic test at the time of illness OR
    • A positive serological test for SARS-CoV-2 antibodies after recovery
  • Complete resolution of symptoms at least 14 days prior to donation and a documented negative COVID-19 FDA approved test OR
  • Complete resolution of symptoms at least 28 days prior to donation

As a part of your pre-donation process you will be required to provide your COVID-19 test result(s), OneBlood says.

Hospitalized patients who are interested in receiving a transfusion will have to consent to the trial, and must be a blood match to a donor, OneBlood says.


You May Also Like
Clamor Grows for More PPP

Anticipation is growing for Congress to free up another batch of PPP loans for small businesses as part of additional legislation to respond to the economic fallout from the COVID-19

Read More
Heroes of the Pandemic

By Clarissa Buch and Sally-Ann O’Dowd • photography (where indicated) by Eduardo Schneider “It’s so terrifying because as a pregnant female, I’m considered immuno-compromised. If I get infected, my immune

Read More
Business as usual

In the aftermath of our spring feature on how companies were dealing with the shutdown, businesses from all over South Florida continue to share their pandemic stories with SFBW. Here

Read More
Business as usual

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”2/3″][vc_column_text] By SFBW editorial staff Kevin Sheehan Jr. President, Bahamas Paradise Cruise Line Business backstory: The only two-night cruise sailing from the

Read More
Other Posts
Stanley Cup Champion Aleksander Barkov Scores Off the Ice

His charity work helps benefit children at South Florida hospitals.

Read More
Amerant Bank Appoints Jesse Flowers as Palm Beach Market President

The company plans to open its third Palm Beach banking center and regional office set to open in 2025.

Read More
Amerant Bank Jesse Flowers
Inaugural Eudēmonia Summit in West Palm Beach Focuses on Health and Well-Being

The creators of Wanderlust Festival launched the event.

Read More
Eudēmonia summit

Drew Limsky

Drew Limsky



Drew Limsky joined Lifestyle Media Group in August 2020 as Editor-in-Chief of South Florida Business & Wealth. His first issue of SFBW, October 2020, heralded a reimagined structure, with new content categories and a slew of fresh visual themes. “As sort of a cross between Forbes and Robb Report, with a dash of GQ and Vogue,” Limsky says, “SFBW reflects South Florida’s increasingly sophisticated and dynamic business and cultural landscape.”

Limsky, an avid traveler, swimmer and film buff who holds a law degree and Ph.D. from New York University, likes to say, “I’m a doctor, but I can’t operate—except on your brand.” He wrote his dissertation on the nonfiction work of Joan Didion. Prior to that, Limsky received his B.A. in English, summa cum laude, from Emory University and earned his M.A. in literature at American University in connection with a Masters Scholar Award fellowship.

Limsky came to SFBW at the apex of a storied career in journalism and publishing that includes six previous lead editorial roles, including for some of the world’s best-known brands. He served as global editor-in-chief of Lexus magazine, founding editor-in-chief of custom lifestyle magazines for Cadillac and Holland America Line, and was the founding editor-in-chief of Modern Luxury Interiors South Florida. He also was the executive editor for B2B magazines for Acura and Honda Financial Services, and he served as travel editor for Conde Nast. Magazines under Limsky’s editorship have garnered more than 75 industry awards.

He has also written for many of the country’s top newspapers and magazines, including The New York Times, Washington Post, Los Angeles Times, Miami Herald, Boston Globe, USA Today, Worth, Robb Report, Afar, Time Out New York, National Geographic Traveler, Men’s Journal, Ritz-Carlton, Elite Traveler, Florida Design, Metropolis and Architectural Digest Mexico. His other clients have included Four Seasons, Acqualina Resort & Residences, Yahoo!, American Airlines, Wynn, Douglas Elliman and Corcoran. As an adjunct assistant professor, Limsky has taught journalism, film and creative writing at the City University of New York, Pace University, American University and other colleges.